Myriam Curet Sells 9,000 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) EVP Myriam Curet sold 9,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the transaction, the executive vice president now owns 217 shares in the company, valued at approximately $48,825. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Intuitive Surgical Trading Down 0.2 %

ISRG stock opened at $230.17 on Friday. The stock has a market capitalization of $82.20 billion, a PE ratio of 58.57, a price-to-earnings-growth ratio of 5.42 and a beta of 1.27. Intuitive Surgical, Inc. has a 12-month low of $186.83 and a 12-month high of $369.69. The stock’s 50 day simple moving average is $211.01 and its 200 day simple moving average is $252.32.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last released its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.13. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same period in the previous year, the firm posted $1.42 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 4.24 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on ISRG shares. Stifel Nicolaus reduced their target price on Intuitive Surgical from $325.00 to $270.00 in a report on Monday, July 18th. BTIG Research reduced their target price on Intuitive Surgical from $355.00 to $247.00 and set a “buy” rating on the stock in a report on Monday, July 18th. Truist Financial reduced their target price on Intuitive Surgical from $270.00 to $255.00 and set a “buy” rating on the stock in a report on Friday, July 22nd. Morgan Stanley reduced their target price on Intuitive Surgical from $300.00 to $225.00 and set an “equal weight” rating on the stock in a report on Friday, July 15th. Finally, Wolfe Research started coverage on Intuitive Surgical in a report on Tuesday, April 5th. They set a “peer perform” rating and a $315.00 target price on the stock. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $265.92.

Hedge Funds Weigh In On Intuitive Surgical

Hedge funds and other institutional investors have recently modified their holdings of the company. Hexagon Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 200.0% during the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 46 shares during the period. Paragon Capital Management Ltd bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Hanseatic Management Services Inc. lifted its holdings in shares of Intuitive Surgical by 200.0% during the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 48 shares during the period. Standard Family Office LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $27,000. Finally, Amplius Wealth Advisors LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. 83.69% of the stock is owned by institutional investors.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Articles

Want More Great Investing Ideas?

Receive News & Ratings for Intuitive Surgical Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical and related companies with MarketBeat.com’s FREE daily email newsletter.